TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
7.06
+0.36 (5.37%)
At close: Dec 5, 2025, 4:00 PM EST
7.20
+0.14 (1.98%)
After-hours: Dec 5, 2025, 6:57 PM EST
TriSalus Life Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 40.21 | 29.43 | 18.51 | 12.4 | 8.4 | 5.43 |
| Revenue Growth (YoY) | 49.52% | 58.99% | 49.31% | 47.58% | 54.60% | - |
| Cost of Revenue | 6.42 | 4.1 | 2.61 | 2.26 | 1.19 | 2.2 |
| Gross Profit | 33.79 | 25.33 | 15.91 | 10.14 | 7.21 | 3.24 |
| Selling, General & Admin | 49.69 | 43.81 | 36.25 | 25.22 | 17.02 | 13.06 |
| Research & Development | 15.35 | 17.69 | 29.84 | 21.36 | 14.22 | 15.83 |
| Operating Expenses | 65.04 | 61.49 | 66.08 | 46.58 | 31.24 | 28.88 |
| Operating Income | -31.26 | -36.17 | -50.18 | -36.44 | -24.03 | -25.65 |
| Interest Expense | -5.16 | -3.09 | -0.02 | -0 | -1.76 | -6.04 |
| Interest & Investment Income | 0.44 | 0.4 | 0.43 | 0.18 | - | - |
| Other Non Operating Income (Expenses) | -5.17 | -2.42 | -17.11 | -10.92 | -0.46 | -0.14 |
| EBT Excluding Unusual Items | -41.15 | -41.27 | -66.87 | -47.18 | -26.25 | -31.83 |
| Merger & Restructuring Charges | - | - | -4.3 | - | - | - |
| Other Unusual Items | 1.57 | 11.23 | 11.81 | - | -2.59 | - |
| Pretax Income | -39.58 | -30.04 | -59.35 | -47.18 | -28.84 | -31.83 |
| Income Tax Expense | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 |
| Net Income | -39.58 | -30.05 | -59.36 | -47.19 | -28.85 | -31.83 |
| Preferred Dividends & Other Adjustments | 31.25 | 3.19 | 4.24 | 2.83 | - | - |
| Net Income to Common | -70.83 | -33.23 | -63.6 | -50.02 | -28.85 | -31.83 |
| Shares Outstanding (Basic) | 33 | 25 | 9 | 0 | 9 | 8 |
| Shares Outstanding (Diluted) | 33 | 25 | 9 | 0 | 9 | 8 |
| Shares Change (YoY) | 36.08% | 169.61% | 2934.71% | -96.51% | 15.52% | - |
| EPS (Basic) | -2.14 | -1.31 | -6.77 | -161.55 | -3.25 | -4.15 |
| EPS (Diluted) | -2.14 | -1.31 | -6.77 | -161.55 | -3.25 | -4.15 |
| Free Cash Flow | -22.16 | -41.19 | -51.17 | -32.97 | -23.79 | -16.13 |
| Free Cash Flow Per Share | -0.67 | -1.63 | -5.45 | -106.48 | -2.68 | -2.10 |
| Gross Margin | 84.04% | 86.06% | 85.93% | 81.79% | 85.80% | 59.55% |
| Operating Margin | -77.73% | -122.88% | -271.06% | -293.91% | -286.06% | -471.95% |
| Profit Margin | -176.16% | -112.92% | -343.59% | -403.42% | -343.35% | -585.76% |
| Free Cash Flow Margin | -55.12% | -139.95% | -276.41% | -265.91% | -283.23% | -296.74% |
| EBITDA | -30.56 | -35.42 | -49.49 | -36.04 | -23.57 | -25.33 |
| EBITDA Margin | -76.01% | -120.35% | -267.36% | -290.70% | -280.54% | - |
| D&A For EBITDA | 0.69 | 0.74 | 0.68 | 0.4 | 0.46 | 0.32 |
| EBIT | -31.26 | -36.17 | -50.18 | -36.44 | -24.03 | -25.65 |
| EBIT Margin | -77.73% | -122.88% | -271.06% | -293.91% | -286.06% | - |
| Advertising Expenses | - | 0.5 | 1.3 | - | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.